Friend John E. II
SEC insider (Form 3/4/5 filer). CIK 0001704021. Chief Executive Officer at KAZIA THERAPEUTICS LTD (KZIA). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2026. Located in SYDNEY, NSW.
Companies Friend John E. II has filed insider reports for
- KAZIA THERAPEUTICS LTD (KZIA): Officer, Chief Executive Officer
Friend John E. II
CIK: 0001704021
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KZIA
KAZIA THERAPEUTICS LTD
Officer